05/08/2012
https://congress.gov...
"This hearing today has very real implications for patients everywhere. How do we ensure that drug and device companies have the right incentives to discover important new treatments for disease?"
"We cannot legislate scientific advances. In some areas, the lack of new treatments is attributable to a lack of scientific knowledge, not the lack of incentives."
"The good news is that innovation in this country is flourishing. More important new drugs are launched here than any place else in the world."
"The foundation laid by the Hatch-Waxman Act thirty years ago will continue to be the mechanism by which the government incentivizes development of lifesaving drugs"